arrow
M

Matthias Becker

Eberhard Karls University of Tubingen
H指数:16
被引数:1,796

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients
2022-10-0613
OAAI
Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants
2022-07-157
OAAI
COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants
2022-05-0315
OAAI
Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination
2022-04-0113
OAAI
Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany
2022-02-167
OAAI
Robust and durable serological response following pediatric SARS-CoV-2 infection

小儿SARS-CoV-2感染后稳健持久的血清学反应

2022-01-1055
OAAI
Biparatopic nanobodies protect mice from lethal challenge with SARS-CoV-2 variants of concern

双互补位纳米抗体可保护小鼠免受SARS-CoV-2变异的致命攻击

2021-12-2019
OA
Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses
2021-12-0131
OAAI
Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis

SARS-CoV-2 mRNA疫苗在血液透析患者中的细胞和体液免疫原性

2021-08-0140
OAAI
Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
2021-05-2591
OAAI
NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodies

NeutrobodyPlex-使用纳米抗体监测SARS-CoV-2中和免疫反应

2021-04-2737
OA
Multiplexed Serum Antibody Screening Platform Using Virus Extracts from Endemic Coronaviridae and SARS-CoV-2
2021-03-165
OAAI
Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
2021-02-1955
OAAI